Araştırma Makalesi

The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome

Cilt: 5 Sayı: 2 30 Haziran 2022
PDF İndir
TR EN

The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome

Öz

Introduction: Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder. Higher CRP levels has been found to rise in severe OSAS. The CRP/Prealbumin (CRP/PAB) ratio is a new index of risk of death and poor outcomes. We aimed to compare the CRP/PAB ratio with the severity of OSAS. Material and Methods: In this cross-sectional study, 99 patients with OSAS (mean age=54.34±10.3) were classified into three categories based on severity of OSAS into mild (n: 28 [28.3%]), moderate (n:23 [23.2%]), and severe (n:48 [48.5%]) based on AHI criteria. Results: The mean CRP/PAB ratios were similar among the groups (mild: 0.03± 0.03; moderate=0.02 ± 0.02; severe=0.03 ± 0.04; p=0.759). The demographic and baseline features were similar between the groups. The CRP/PAB ratio had a weak positive correlation with the age, BMI, glucose, neutrophil, platelet and monocyte values and a weak negative correlation with the Hgb, MCH and MCHC values (p<0.05). Considering all groups in the regression analysis, it was showed that low levels of positive and significant relationship between the CRP/PAB and sleep duration and the apnea and hypopnea indices. It was also showed low-level of negative and significant relationship with sleep efficiency (p<0.05 for all). Conclusion: Although, there was no significant between the CRP/PAB ratio and the severity of OSAS, it was showed that low-level positive correlation between CRP/PAB ratio and BMI, monocyte count and low-level relationship with the apnea and hypopnea indices and it may indirectly mean that CRP/PAB ratio may be a significant marker of inflammation in OSAS.

Anahtar Kelimeler

Kaynakça

  1. Framnes SN, Arble DM. The Bidirectional Relationship Between Obstructive Sleep Apnea and Metabolic Disease. Front. Endocrinol. 2018; 9: 440
  2. Tie YX, Fu YY, Xu Z. Peng Y. Relationship between C-reactive protein levels and obstructive sleep apnea syndrome. Genet. Mol. Res. 2016 May 25;15(2).
  3. Davis CJ, Sowa D, Keim KS, Kinnare K, Peterson S. The Use of Prealbumin and C-Reactive Protein for Monitoring Nutrition Support in Adult Patients Receiving Enteral Nutrition in an Urban Medical Center. Journal of Parenteral and Enteral Nutrition. 2012 Mar;36(2):197-204.
  4. Molfino A, Heymsfield SB, Zhu F, Kotanko P, Levin NW, Dwyer T, et al. Prealbumin is Associated with Visceral Fat Mass in Hemodialysis Patients. Ren Nutr. 2013 November; 23(6): 406–410
  5. Wang W, Ren D, Wang CS, Li T, Yao HC. High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome. Scientific Reports. 2019; 9: 11583
  6. Li L, Dai L, Wang X, Wang Y, Zhou L, Chen M, et al. Predictive value of the C-reactive protein-to-prealbumin ratio in medical ICU patients. Biomark Med. 2017 Apr; 11(4): 329-337.
  7. Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017; 13(3): 479–504
  8. Bouloukaki I, Mermigkis C, Kallergis EM, Moniaki V, Mauroidi E, Schize SE. Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive protein. World J Exp Med. 2015 May 20; 5(2): 77-83

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

30 Haziran 2022

Gönderilme Tarihi

26 Ocak 2022

Kabul Tarihi

8 Haziran 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 5 Sayı: 2

Kaynak Göster

APA
Boduroğlu, Y., Zorlu, D., İlanbey, B., & Ertürk, A. (2022). The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome. Medical Research Reports, 5(2), 49-61. https://doi.org/10.55517/mrr.1062670
AMA
1.Boduroğlu Y, Zorlu D, İlanbey B, Ertürk A. The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome. MRR. 2022;5(2):49-61. doi:10.55517/mrr.1062670
Chicago
Boduroğlu, Yalçın, Duygu Zorlu, Bilal İlanbey, ve Arzu Ertürk. 2022. “The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome”. Medical Research Reports 5 (2): 49-61. https://doi.org/10.55517/mrr.1062670.
EndNote
Boduroğlu Y, Zorlu D, İlanbey B, Ertürk A (01 Haziran 2022) The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome. Medical Research Reports 5 2 49–61.
IEEE
[1]Y. Boduroğlu, D. Zorlu, B. İlanbey, ve A. Ertürk, “The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome”, MRR, c. 5, sy 2, ss. 49–61, Haz. 2022, doi: 10.55517/mrr.1062670.
ISNAD
Boduroğlu, Yalçın - Zorlu, Duygu - İlanbey, Bilal - Ertürk, Arzu. “The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome”. Medical Research Reports 5/2 (01 Haziran 2022): 49-61. https://doi.org/10.55517/mrr.1062670.
JAMA
1.Boduroğlu Y, Zorlu D, İlanbey B, Ertürk A. The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome. MRR. 2022;5:49–61.
MLA
Boduroğlu, Yalçın, vd. “The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome”. Medical Research Reports, c. 5, sy 2, Haziran 2022, ss. 49-61, doi:10.55517/mrr.1062670.
Vancouver
1.Yalçın Boduroğlu, Duygu Zorlu, Bilal İlanbey, Arzu Ertürk. The Relationship Between Disease Severity and CRP/Prealbumin Ratio in Individuals Diagnosed with Obstructive Sleep Apnea Syndrome. MRR. 01 Haziran 2022;5(2):49-61. doi:10.55517/mrr.1062670